JMAC Enterprises’s Jazz Pharmaceuticals JAZZ Stock Holding History

JMAC Enterprises’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$831K	Hold	3,450	–	–	0.14%	74
2026 Q1	$652K	Hold	3,450	–	–	0.12%	80
2025 Q4	$587K	Hold	3,450	–	–	0.11%	82
2025 Q3	$455K	Hold	3,450	–	–	0.09%	93
2025 Q2	$366K	Sell	3,450 -250	-7%	-$27.2K	0.08%	98
2025 Q1	$459K	Hold	3,700	–	–	0.11%	91
2024 Q4	$456K	Hold	3,700	–	–	0.07%	136
2024 Q3	$412K	Hold	3,700	–	–	0.07%	141
2024 Q2	$395K	Hold	3,700	–	–	0.07%	139
2024 Q1	$446K	Sell	3,700 -500	-12%	-$61.2K	0.08%	126
2023 Q4	$517K	Hold	4,200	–	–	0.11%	121
2023 Q3	$544K	Sell	4,200 -600	-13%	-$79.9K	0.13%	116
2023 Q2	$595K	Hold	4,800	–	–	0.15%	109
2023 Q1	$702K	Hold	4,800	–	–	0.18%	102
2022 Q4	$765K	Hold	4,800	–	–	0.21%	100
2022 Q3	$640K	Hold	4,800	–	–	0.18%	110
2022 Q2	$749K	Sell	4,800 -600	-11%	-$92.4K	0.19%	106
2022 Q1	$841K	Hold	5,400	–	–	0.2%	98
2021 Q4	$758K	Buy	+5,400	New	+$710K	0.18%	101

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

JMAC Enterprises's JAZZ Position: Q2 2026 in Review

JMAC Enterprises held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 3,450 shares worth $831K. The position accounts for 0.14% of the portfolio, ranked #74.

JMAC Enterprises first reported a position in JAZZ in Q4 2021 and has held it in 19 quarters since. The position peaked at $841K in Q1 2022. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

JMAC Enterprises held 3,450 shares of Jazz Pharmaceuticals worth $831K as of Q2 2026.
JMAC Enterprises left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
Jazz Pharmaceuticals made up 0.14% of JMAC Enterprises's portfolio in Q2 2026, its #74 holding.
JMAC Enterprises first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
JMAC Enterprises's Jazz Pharmaceuticals position peaked at $841K in Q1 2022.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on JMAC Enterprises's 13F filing for Q2 2026, filed 28 Jul 2026.